The government on 1st February 2024 appointed Dr. Rajeev Singh Raghuvanshi as Drug Controller General of India. The government earlier on 14 August 2024 appointed Dr. VG Somani as Drug Controller General of India (DCGI). Dr. VG Somani succeeded S Eswara Reddy, the interim DCGI who was appointed in February 2024. DCGI heads the Indian drug regulatory body the Central Drugs Standard Control Organisation (CDSCO), whose functions include ensuring t… WebDiclofenac Potassium 50mg + Serratiopeptidase (as For the treatment of 108 enteric coated pellets) 15mg capsules (Additional acute pain in adults Strength) For the treatment of …
Drug developed using DRDO technology gets DCGI approval
WebCentral Drugs Standard Control Organization. As set forth in the 2024-CTRules and the Hdbk-ClinTrial, the Central Drugs Standard Control Organization (CDSCO) is the … WebThe Central Drugs Standard Control Organisation (CDSCO) under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India. Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and also has six zonal offices,four sub zonal offices,thirteen ... robert wang csis
CDSCO
WebNew drug(NDA & sNDA)- Form 45, Registration/Renewal- Form 41/10, Query Reponses, Variations, Merger, Legal entity name change (LENC) of global sites, Office relocation Applications to DCGI Worked with Pfizer’s software’s- GRS, GDMS, Epalms, label central, etc. WebApr 10, 2024 · The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2024, in the 12-17 age group on March 9 and also in children aged 7-11 years on 28 June, 2024 subject ... http://www.pharmabiz.com/NewsDetails.aspx?aid=90886&sid=16 robert waples